NeuroMetrix, Inc. (NURO)

NeuroMetrix Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	5.27	5.9	8.26	8.25	7.38	9.27
Revenue Growth (YoY)	-31.36%	-28.52%	0.03%	11.87%	-20.43%	-42.37%
Cost of Revenue	2	1.95	2.51	2.33	2.13	7.03
Gross Profit	3.27	3.95	5.75	5.92	5.25	2.25
Selling, General & Admin	8.94	8.32	7.25	5.61	4.95	10.68
Research & Development	3.02	2.78	3.24	2.6	2.39	3.1
Operating Expenses	11.96	11.1	10.49	8.21	7.34	13.78
Operating Income	-8.7	-7.15	-4.74	-2.28	-2.09	-11.53
Other Expense / Income	-0.71	-0.62	-0.33	-0	-0	-7.76
Pretax Income	-7.98	-6.53	-4.42	-2.28	-2.09	-3.77
Net Income	-7.98	-6.53	-4.42	-2.28	-2.09	-3.77
Shares Outstanding (Basic)	2	1	1	1	0	0
Shares Change	88.57%	10.75%	16.73%	75.59%	286.91%	32.81%
EPS (Basic)	-6.26	-6.27	-4.97	-3.60	-5.52	-31.20
EPS (Diluted)	-6.26	-6.27	-4.97	-3.60	-5.52	-31.20
Free Cash Flow	-7.23	-6.27	-5.31	-2.21	-2.07	-3.67
Free Cash Flow Per Share	-3.99	-5.84	-5.48	-2.65	-4.37	-30.01
Gross Margin	61.97%	66.89%	69.65%	71.75%	71.15%	24.22%
Operating Margin	-164.99%	-121.18%	-57.43%	-27.68%	-28.39%	-124.40%
Profit Margin	-151.51%	-110.64%	-53.50%	-27.64%	-28.36%	-40.69%
Free Cash Flow Margin	-137.16%	-106.22%	-64.35%	-26.72%	-28.01%	-39.57%
EBITDA	-7.91	-6.47	-4.37	-2.21	-2	-3.65
EBITDA Margin	-150.17%	-109.70%	-52.90%	-26.72%	-27.14%	-39.35%
Depreciation & Amortization	0.07	0.06	0.05	0.08	0.09	0.12
EBIT	-7.98	-6.53	-4.42	-2.28	-2.09	-3.77
EBIT Margin	-151.51%	-110.64%	-53.50%	-27.64%	-28.36%	-40.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).